The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
Frequently asked questions
What is the ProShares UltraShort Nasdaq Biotechnology (BIS) expense ratio?
The ProShares UltraShort Nasdaq Biotechnology funds expense ratio is 0.95%.
What is ProShares UltraShort Nasdaq Biotechnology (BIS) current stock price?
As of the latest data, ProShares UltraShort Nasdaq Biotechnology stock price is $12.07, with a previous close of $12.30. ProShares UltraShort Nasdaq Biotechnology lost -$0.23 in the last trading session, representing a -1.87% loss.
Does ProShares UltraShort Nasdaq Biotechnology (BIS) pay dividends?
Yes. ProShares UltraShort Nasdaq Biotechnology pays quarterly dividends with an annualized yield of 6.54% and an estimated annual payout of $0.79 per share.